NCT00382148View on ClinicalTrials.gov

A Study of Xolair in Peanut-Allergic Subjects Previously Enrolled in Study Q2788g

PHASE2CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

June 30, 2008

Conditions

Peanut Hypersensitivity

Interventions

DRUG

omalizumab

SC repeating dose

Sponsors

Lead Sponsor

Genentech, Inc.

All Listed Sponsors

lead

Genentech, Inc.

INDUSTRY